Rick J. Verhines

CellFor is the world's leading independent supplier of high technology seedlings to the global forest industry. Using plant biotechnology, which is the use of biological processes to manufacture products, CellFor identifies and produces genetically superior conifer seedlings without genetic modification. It's not a position they have earned by being the biggest seedling producer in the world, but by being the first to tap into the promise of plant biotechnology to mass produce high quality, top performing conifer seedlings more quickly, more dependably, and in far greater quantities than ever before. CellFor corporate headquarters is based in Vancouver, British Columbia, with the primary research and development, laboratory and production facilities located north of Victoria, on Vancouver Island. They have more than 200 scientists and technicians at their facilities in and around Victoria, where they are producing somatic embryos and seedlings on a commercial scale for customers in North America, South America and Australasia. In addition, CellFor has a Sales and Marketing team located in Atlanta, Georgia.

Thibiant International, Inc. provides hair care products which include conditioners, shampoos, and sprays. Its skin care products include after shave and aromatherapy products, baby oils, bubble bath products, cosmeceuticals, creams, lotions, mouthwash products, pharmaceuticals, pre-shave lotions, liquid soaps, and skin treatments. The company was founded in 1976 and is headquartered in Chatsworth, CA.

Part of Energy Transfer LP, Johnson & Johnson Propane, Inc. is a company that distributes propane products. The company is based in Madison, FL.

Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ.